MK0974, a totally new kind of Migraine abortive, is now in Phase III clinical trials, the last phase before Merck seeks FDA approval of the medication. ...
http://www.healthcentral.com/migraine/news-265068-98.html
... The medication is still know by a number, MK0974, and is being developed by Merck. ... (First Migraine); Patient has previously taken MK0974. ...
http://www.healthcentral.com/migraine/c/123/42457/interested-migraine
... Institutes of Health) UPDATED 2009-01-19. This is a study to assess the safety and effectiveness of a new drug--currently known as MK0974--for preventing ...
http://www.healthcentral.com/migraine/news-281243-98.html
You may remember that I interviewed Dr. Tony Ho about a new Migraine abortive medication at last year's American Headache Society conference. If you didn't read ...
http://www.healthcentral.com/migraine/c/123/42457/comments
... (National Institutes of Health) UPDATED 2008-06-11. This is a study to evaluate the safety and effectiveness of a new migraine med (MK0974) in the treatment of ...
http://www.healthcentral.com/migraine/news-269903-98.html
... Shows Promise without Vasoconstriction. The medication is still know by a number, MK0974, and is being developed by Merck. It is now ...
http://forums.healthcentral.com/discussion/migraine/forums/a/tpc/f/2381036/m/951...
... This is a study is to assess the safety and effectiveness of a new drug (MK0974) for the acute treatment of multiple migraine attacks with or without aura. ...
http://www.healthcentral.com/migraine/news-264386-98.html
... In a recent study, one of these medicines, MK0974, reduced pain and was better at preventing the return of migraine pain than existing triptan drugs. ...
http://www.healthcentral.com/migraine/news-269905-98.html
... Shows Promise without Vasoconstriction. The medication is still know by a number, MK0974, and is being developed by Merck. It is now ...
http://forums.healthcentral.com/discussion/migraine/forums/a/tpc/f/2381036/m/351...
... Shows Promise without Vasoconstriction. The medication is still know by a number, MK0974, and is being developed by Merck. It is now ...
http://forums.healthcentral.com/discussion/migraine/forums/a/tpc/f/2381036/m/951...